NATCO applies to CDSCO for EUA of Molnupiravir capsules to treat COVID-19
Pre-clinical data have shown that Molnupiravir has broad anti-influenza activity, including highly potent inhibition of SARS-CoV-2…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
emergency approval
MHRA issues anaphylaxis warning for Pfizer BioNTech vaccine
Pfizer and BioNTech said they were supporting the MHRA’s investigation